SOX17 and esophageal squamous cell carcinoma: Here, we show for the first time that SOX17 functions as a NRF2 upstream transcriptional suppressor, and dysregulation of SOX17/NRF2 pathway confers CCRT resistance and aggressiveness in ESCC cells.